Cargando…

A novel methylation signature predicts inferior outcome of patients with PDAC

Pancreatic ductal adenocarcinoma (PDAC) will become the second most common cause of death in North America and Europe over the next 10 years owing to the lack of early diagnosis, poor treatment, and poor prognosis. This study evaluated the methylation array data of 184 patients with PDAC in The Canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Minqi, Sun, Jing, Zhang, Shunhao, Chen, Jing, Wang, Guihua, Ju, Shaoqing, Wang, Xudong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880369/ https://www.ncbi.nlm.nih.gov/pubmed/33550277 http://dx.doi.org/10.18632/aging.202347

Ejemplares similares

Circular RNA: A promising new star for the diagnosis and treatment of colorectal cancer
por: Zhang, Shunhao, et al.
Publicado: (2021)

Overexpression of small nucleolar RNA SNORD1C is associated with unfavorable outcome in colorectal cancer
por: Liu, Yonghui, et al.
Publicado: (2021)

Circulating EVs long RNA-based subtyping and deconvolution enable prediction of immunogenic signatures and clinical outcome for PDAC
por: Li, Yuchen, et al.
Publicado: (2021)

Overexpression of Mesothelin in Pancreatic Ductal Adenocarcinoma (PDAC)
por: Le, Kai, et al.
Publicado: (2020)

The role of survivin in the progression of pancreatic ductal adenocarcinoma (PDAC) and a novel survivin-targeted therapeutic for PDAC
por: Brown, Matthew, et al.
Publicado: (2020)

Copy number variations primed lncRNAs deregulation contribute to poor prognosis in colorectal cancer
por: Liu, Huimin, et al.
Publicado: (2019)

Large tumor suppressor 2 is a prognostic biomarker and correlated with immune infiltrates in colorectal cancer
por: Zhao, Chengwen, et al.
Publicado: (2021)

Overexpression of GRO-β is associated with an unfavorable outcome in colorectal cancer
por: WANG, GUIHUA, et al.
Publicado: (2016)

Autophagy is required for PDAC glutamine metabolism
por: Seo, Ju-Won, et al.
Publicado: (2016)

MicroRNA profiling of pancreatic ductal adenocarcinoma (PDAC) reveals signature expression related to lymph node metastasis
por: Lemberger, Moran, et al.
Publicado: (2019)

AHNAK2 is a potential prognostic biomarker in patients with PDAC
por: Lu, Di, et al.
Publicado: (2017)

SIRT 1 Overexpression is Associated with Metastasis of Pancreatic Ductal Adenocarcinoma (PDAC) and Promotes Migration and Growth of PDAC Cells
por: Li, Siqin, et al.
Publicado: (2016)

SNORD1C maintains stemness and 5-FU resistance by activation of Wnt signaling pathway in colorectal cancer
por: Liu, Yonghui, et al.
Publicado: (2022)

Scaling the immune incline in PDAC
por: Rojas, Luis A., et al.
Publicado: (2021)

Circulating Tumor Cell Subpopulations Predict Treatment Outcome in Pancreatic Ductal Adenocarcinoma (PDAC) Patients
por: Freed, Ian M., et al.
Publicado: (2023)

TIMP-1 and CD82, a promising combined evaluation marker for PDAC
por: Zhang, Jiexin, et al.
Publicado: (2016)

A novel prognostic factor TIPE2 inhibits cell proliferation and promotes apoptosis in pancreatic ductal adenocarcinoma (PDAC)
por: Sun, Yuqi, et al.
Publicado: (2021)

Transverse Space Charge Effect During Bunch Compression in PDAC1 and PDAC2 Compressor Ring
por: Franchetti, Giuliano
Publicado: (2000)

BET inhibition is an effective approach against KRAS-driven PDAC and NSCLC
por: Jauset, Toni, et al.
Publicado: (2018)

C/EBPδ Suppresses Motility-Associated Gene Signatures and Reduces PDAC Cell Migration
por: Hartl, Leonie, et al.
Publicado: (2022)

The GSK3β inhibitor BIS I reverts YAP-dependent EMT signature in PDAC cell lines by decreasing SMADs expression level
por: Thongon, Natthakan, et al.
Publicado: (2016)

MUC4-promoted neural invasion is mediated by the axon guidance factor netrin-1 in PDAC
por: Wang, Linjun, et al.
Publicado: (2015)

Targeting KRAS in PDAC: A New Way to Cure It?
por: He, Qianyu, et al.
Publicado: (2022)

The Microbiome in PDAC—Vantage Point for Future Therapies?
por: Pfisterer, Nina, et al.
Publicado: (2022)

The role of Jagged1 as a dynamic switch of cancer cell plasticity in PDAC assembloids
por: Choi, Jae-Il, et al.
Publicado: (2022)

Immune-related somatic mutation genes are enriched in PDACs with diabetes
por: Wang, Kaixuan, et al.
Publicado: (2019)

SDC1 and ITGA2 as novel prognostic biomarkers for PDAC related to IPMN
por: Zhang, Chuan-long, et al.
Publicado: (2023)

Prediction of Tumor Cellularity in Resectable PDAC from Preoperative Computed Tomography Imaging
por: Jungmann, Friederike, et al.
Publicado: (2021)

RELA-induced MiR-21 Exerts Oncogenic Effects on PDAC via Targeting of ARHGAP24
por: Yu, Lanting, et al.
Publicado: (2022)

Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia
por: Wang, Jie, et al.
Publicado: (2021)

Tumor-Specific miRNA Signatures in Combination with CA19-9 for Liquid Biopsy-Based Detection of PDAC
por: Kim, Min Woo, et al.
Publicado: (2021)

CypA, a Gene Downstream of HIF-1α, Promotes the Development of PDAC
por: Zhang, Huan, et al.
Publicado: (2014)

A Novel Pseudogene Methylation Signature to Predict Temozolomide Outcome in Non-G-CIMP Glioblastomas
por: Li, Bowen, et al.
Publicado: (2022)

Integrated analysis revealed hypoxia signatures and LDHA related to tumor cell dedifferentiation and unfavorable prognosis in pancreatic adenocarcinoma: Hypoxia in PDAC
por: Dong, Mingwei, et al.
Publicado: (2023)

A novel ferroptosis-related gene signature for predicting outcomes in cervical cancer
por: Qi, Xingling, et al.
Publicado: (2021)

BAG3 regulates stability of IL-8 mRNA via interplay between HuR and miR-4312 in PDACs
por: Li, Chao, et al.
Publicado: (2018)

SMAD4 Y353C promotes the progression of PDAC
por: Wang, Zusen, et al.
Publicado: (2019)

Preoperative neutrophil-to-lymphocyte ratio and tumor-related factors to predict lymph node metastasis in patients with pancreatic ductal adenocarcinoma (PDAC)
por: Tao, Lianyuan, et al.
Publicado: (2016)

ENO1 expression and Erk phosphorylation in PDAC and their effects on tumor cell apoptosis in a hypoxic microenvironment
por: Sun, Huizhi, et al.
Publicado: (2022)

KRAS-mutant colon cancer cells respond to combined treatment of ABT263 and axitinib
por: Wang, Guihua, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lo85db772o5j8mjc7ee714av3r